CJC-1295 with DAC – 5mg

For Research Use Only – Not for Human Consumption

CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic peptide analog of Growth Hormone Releasing Hormone (GHRH). The addition of DAC extends its half-life dramatically, allowing for sustained GH release in research models for up to 7–10 days after a single administration.

This version offers a 5mg unit size, ideal for longer-term or higher-dosage experimental protocols.

Key Research Areas:

• Sustained GH & IGF-1 Stimulation: Proven in studies to increase growth hormone and IGF-1 levels over extended periods.

• Improved Recovery & Regeneration: Explored for its potential role in tissue repair and cellular rejuvenation.

• Anabolic & Lipolytic Effects: Commonly studied for possible impacts on muscle development and fat metabolism.

• Extended Half-Life: DAC binding allows for weekly or bi-weekly dosing schedules in research.

Specifications:

• Unit Size: 5mg

• Purity: ≥99%

• Form: Lyophilized powder

• Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂

• Storage:

•  

  • Reconstituted: Store at 2–8°C; use within 30 days

   

Important:
This product is sold for laboratory research use only. It is not intended for human consumption or for use in diagnostic or therapeutic applications.